Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...
The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.
Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.
GREENVILLE, N.C. (WITN) - An Eastern Carolina hospital recently performed its first procedure with a new and innovative ...
Boston Scientific reported that electrophysiology sales grew 172% in Q4 2024, driven by an uptake of its Farapulse pulsed field ablation (PFA) system. Revealing its Q4 and full-year results ...
Steven Mickelsen, the electrophysiologist who founded Farapulse before it was sold to Boston Scientific in 2021, is taking pulsed field ablation into new territory with the development of a device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results